Parental acceptance of Human Papillomavirus vaccines

Lenselink, Charlotte H.; Gerrits, Marloes; Melchers, Willem J. G.; Massuger, Leon F.A.G.; Hamont, Dennis van; Bekkers, Ruud L.M.

doi:10.1016/j.ejogrb.2007.02.012

Cited by 106 publications

(118 citation statements)

References 22 publications

Supporting

Mentioning

107

Contrasting

Unclassified

Order By: Relevance

“…Inevitably, it is likely that those responding over-represent the more engaged, articulate parents with stronger views. A return rate of 60%, representing a quarter of the general population, is comparable to telephone surveys on HPV acceptability (Constantine and Jerman, 2007;Ogilvie et al, 2007) and higher than a Dutch postal survey (Lenselink et al, 2008). Parents who do not return questionnaires may also be less responsive to a vaccine invitation.…”

Section: Discussionmentioning

confidence: 78%

Parental attitudes and information needs in an adolescent HPV vaccination programme

et al. 2008

View full text Add to dashboard Cite

We sent a questionnaire to 38% (1084) of 2817 parents whose daughters had been offered human papillomavirus vaccination and who had agreed to participate. Of these, 60% (651) returned a questionnaire. Responses suggested that fact sheets and parent information evenings confirmed, rather than changed, consent decisions. The views of active refusers on safety and efficacy may be difficult to change, lowering vaccine coverage. British Journal of Cancer (2008Cancer ( ) 99, 1908Cancer ( -1911 In the United Kingdom, routine human papillomavirus (HPV) vaccination for 12 -13-year-old girls to prevent cervical cancer has begun. The highest possible vaccine uptake is required to achieve maximum impact on future cancer incidence and to ensure cost effectiveness (Goldhaber-Fiebert et al, 2008). Two parental acceptability studies in the UK anticipated an uptake of about 80% (Brabin et al, 2006;Marlow et al, 2007a), which would be similar to the coverage achieved by the cervical screening programme. As those girls who are not vaccinated may include some who would not take advantage of future cervical screening, reducing non-acceptance is important (Jit et al, 2008).A school-based programme increases the possibility of high coverage, but the acceptability of vaccinating adolescents against a sexually transmitted infection remains uncertain, and the general public is relatively uninformed, or even misinformed, about cervical cancer and its prevention (Friedman and Shepheard, 2007;Marlow et al, 2007b). We assessed vaccine acceptability in a feasibility study ahead of the national vaccine programme. Two primary care trusts (PCTs) in Greater Manchester that offered Cervarix (GlaxoSmithKline, Rixensart, Belgium) to girls attending 36 secondary schools achieved a 71% uptake of the first HPV vaccine dose . Here we present the results of a parental questionnaire survey shortly after the second dose, which focussed on factors that had influenced the parents' vaccine decision and included a small group of respondents who had declined vaccination. MATERIALS AND METHODSThe North Manchester NHS Research Ethics Committee approved the study. Cervarix was offered at 0, 1 and 6 months to 2817 girls aged 12 -13 years between October 2007 and July 2008 . In the covering letter, parents were informed that the funding source was GlaxoSmithKline and that Cervarix was one of two licensed vaccines; it explained that the vaccine for the future national immunisation programme and the policy for vaccinating older girls had not yet been determined. Parents received information about cervical cancer and the vaccine, a flier summarising the content of an educational film for girls (Vallely et al, 2008), details of parent evenings and a separate consent form for the follow-up research questionnaire. Information evenings provided an overview of HPV vaccines and the study aims; the educational film was shown, followed by a question and answer session facilitated either by school nurses or by a consultant in communicable diseases.Primary care trusts forwarded...

show abstract

Section: Discussionmentioning

confidence: 78%

Parental attitudes and information needs in an adolescent HPV vaccination programme

et al. 2008

View full text Add to dashboard Cite

show abstract

“…19 But in contrast, few studies reported that high vaccine acceptance among parents and adolescents in the general population. [20][21][22][23][24] A study by Massey et al indicated low awareness of HPV; among those who had heard of HPV, just 28% were willing to receive the HPV vaccine. 25 Overall vaccination rates were very low in our sample cohort.…”

Section: Discussionmentioning

confidence: 99%

Assessment of knowledge and attitude of medical and nursing students towards screening for cervical carcinoma and HPV vaccination in a tertiary care teaching hospital

Gautam

Barwal

Walia

et al. 2017

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: Cervical cancer is the second most common cancer among women and infection with high risk human papilloma virus (HPV) is a pre-requisite for cervical cancer. The present study was undertaken to assess the knowledge regarding cervical cancer screening and HPV vaccination among medical and nursing staff.Methods: Four hundred participants; 200 MBBS students, 120 BSc nursing students and 80 staff nurses answered a standardized questionnaire which was analysed.Results: Majority of the MBBS students correctly believed that cervical cancer was not the most common cancer in females and 77.5% believed that HPV is identified in more than 50% cases. Around 80% of the respondents knew that HPV is transmitted sexually and could be transmitted during pregnancy and can affect both males and females. More than 80% of the staff nurses answered correctly that HPV could be transmitted by needle sharing and 76% believed that the infection could be symptomless. More than 80% of the participants were aware that a vaccine is available against HPV but only 5.5% were vaccinated. Though the knowledge was there but several gaps were noticed regarding HPV vaccination, the major concerns being safety, efficacy and availability of the vaccine.Conclusions: HPV is a vaccine preventable cancer and for accepting the vaccination the health professionals can play a pivotal role in raising awareness and controlling the disease.

show abstract

“…[32][33][34] Although some studies suggest that knowing about cervical cancer, HPV and HPV vaccines is necessary for vaccine acceptance, 35,36 others report that this knowledge correlates poorly with acceptance 32 and does not predict behaviour. 36 Our data also indicate that parents' primary motivation for having their daughters vaccinated was their perception that the HPV vaccine was good for health, prevented cancer and prevented disease in general, rather than specific knowledge of cervical cancer or HPV. A recent study of hypothetical vaccine acceptability in India found that the HPV vaccine was accepted even by people who knew relatively little about HPV or cervical cancer.…”

Section: Vaccine-related Issues No (%)mentioning

confidence: 99%

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

LaMontagne¹,

Barge²,

Lê³

et al. 2011

Bull World Health Org

113

View full text Add to dashboard Cite

Parental acceptance of Human Papillomavirus vaccines

Cited by 106 publications

References 22 publications

Parental attitudes and information needs in an adolescent HPV vaccination programme

Parental attitudes and information needs in an adolescent HPV vaccination programme

Assessment of knowledge and attitude of medical and nursing students towards screening for cervical carcinoma and HPV vaccination in a tertiary care teaching hospital

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

Contact Info

Product

Resources

About